Silica Nanoparticles: A Promising Vehicle for Anti-Cancer Drugs Delivery

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Oncology

Background:

• Cancer prevalence and mortality are increasing globally.
• Conventional chemotherapy faces challenges with low drug specificity and solubility, necessitating high dosages and causing systemic toxicity.
• Targeted drug delivery systems are crucial for improving cancer treatment efficacy and patient outcomes.

Purpose of the Study:

• To review the synthesis, functionalization, and applications of silica nanoparticles (SiNPs) in cancer therapy.
• To highlight the advantages of SiNPs for delivering various anti-cancer agents, including chemotherapeutics, photosensitizers, and nucleic acids.
• To provide insights into the current status and future potential of SiNPs in revolutionizing cancer treatment.

Main Methods:

• Review of existing literature on silica nanoparticles for cancer therapy.
• Exploration of SiNP synthesis and surface modification techniques.
• Analysis of SiNP applications in delivering diverse therapeutic payloads for cancer treatment.

Main Results:

• SiNPs exhibit advantageous properties for drug delivery, including high drug loading capacity, controlled release kinetics, and targeted delivery capabilities.
• Functionalized SiNPs can enhance the efficacy of chemotherapeutic agents, photosensitizers, and nucleic acids.
• SiNP-based delivery systems demonstrate potential in reducing systemic toxicity associated with cancer therapies.

Conclusions:

• Silica nanoparticles represent a versatile and effective platform for advanced cancer therapy.
• SiNPs can significantly improve therapeutic efficacy and minimize side effects by enabling targeted drug delivery.
• Further research and development of SiNPs hold great promise for transforming cancer treatment paradigms and improving patient outcomes.